102 related articles for article (PubMed ID: 23859000)
1. Synthesis and biological activities of 2,6-dihydroxy-4-isopentenyloxychalcone as an antimicrobial and anti-inflammatory compound.
Bonifait L; Zhao L; Azelmat J; Genovese S; Epifano F; Grenier D
Med Chem; 2014 May; 10(3):300-3. PubMed ID: 23859000
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial and anti-inflammatory activities of 4-hydroxycordoin: potential therapeutic benefits.
Feldman M; Tanabe S; Epifano F; Genovese S; Curini M; Grenier D
J Nat Prod; 2011 Jan; 74(1):26-31. PubMed ID: 21158427
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of acetylenic chalcones as novel anti-inflammatory agents.
Zhao C; Feng J; Zuo M; Zhang Y; Zhao J; Xu S; Zheng S; Zhang Y; Tang Q; Lu Z; Liang G; Zhou J
Med Chem; 2015; 11(6):567-72. PubMed ID: 25665651
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain.
Andrés MT; Chung WO; Roberts MC; Fierro JF
Antimicrob Agents Chemother; 1998 Nov; 42(11):3022-3. PubMed ID: 9797247
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of some novel chalcones, flavanones and flavones and evaluation of their anti-inflammatory activity.
Bano S; Javed K; Ahmad S; Rathish IG; Singh S; Chaitanya M; Arunasree KM; Alam MS
Eur J Med Chem; 2013 Jul; 65():51-9. PubMed ID: 23693150
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate attenuates Porphyromonas gingivalis lipopolysaccharide-enhanced matrix metalloproteinase-1 production through inhibition of interleukin-6 in gingival fibroblasts.
Wen WC; Kuo PJ; Chiang CY; Chin YT; Fu MM; Fu E
J Periodontol; 2014 Jun; 85(6):868-75. PubMed ID: 24215203
[TBL] [Abstract][Full Text] [Related]
7. In vitro anti‑bacterial activity of diosgenin on Porphyromonas gingivalis and Prevotella intermedia.
Cong S; Tong Q; Peng Q; Shen T; Zhu X; Xu Y; Qi S
Mol Med Rep; 2020 Dec; 22(6):5392-5398. PubMed ID: 33174005
[TBL] [Abstract][Full Text] [Related]
8. The Daiokanzoto (TJ-84) Kampo Formulation Reduces Virulence Factor Gene Expression in Porphyromonas gingivalis and Possesses Anti-Inflammatory and Anti-Protease Activities.
Fournier-Larente J; Azelmat J; Yoshioka M; Hinode D; Grenier D
PLoS One; 2016; 11(2):e0148860. PubMed ID: 26859747
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide and prostaglandin E
Mohd Faudzi SM; Abdullah MA; Abdull Manap MR; Ismail AZ; Rullah K; Mohd Aluwi MFF; Mazila Ramli AN; Abas F; Lajis NH
Bioorg Chem; 2020 Jan; 94():103376. PubMed ID: 31677861
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Effects of Mastic Extract Against Oral and Periodontal Pathogens.
Koychev S; Dommisch H; Chen H; Pischon N
J Periodontol; 2017 May; 88(5):511-517. PubMed ID: 28067105
[TBL] [Abstract][Full Text] [Related]
11. Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages.
Feldman M; Grenier D
J Appl Microbiol; 2012 Aug; 113(2):438-47. PubMed ID: 22563853
[TBL] [Abstract][Full Text] [Related]
12. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
[TBL] [Abstract][Full Text] [Related]
13. 2',4-Dihydroxy-3',4',6'-trimethoxychalcone from Chromolaena odorata possesses anti-inflammatory effects via inhibition of NF-κB and p38 MAPK in lipopolysaccharide-activated RAW 264.7 macrophages.
Dhar R; Kimseng R; Chokchaisiri R; Hiransai P; Utaipan T; Suksamrarn A; Chunglok W
Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):43-51. PubMed ID: 29199487
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens.
Aguilera O; Andrés MT; Heath J; Fierro JF; Douglas CW
FEMS Immunol Med Microbiol; 1998 May; 21(1):29-36. PubMed ID: 9657318
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis Lipopolysaccharide Induces a Pro-inflammatory Human Gingival Fibroblast Phenotype.
Bozkurt SB; Hakki SS; Hakki EE; Durak Y; Kantarci A
Inflammation; 2017 Feb; 40(1):144-153. PubMed ID: 27812843
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor δ inhibits Porphyromonas gingivalis lipopolysaccharide-induced activation of matrix metalloproteinase-2 by downregulating NADPH oxidase 4 in human gingival fibroblasts.
Yoo T; Ham SA; Hwang JS; Lee WJ; Paek KS; Oh JW; Kim JH; Do JT; Han CW; Kim JH; Seo HG
Mol Oral Microbiol; 2016 Oct; 31(5):398-409. PubMed ID: 26403493
[TBL] [Abstract][Full Text] [Related]
17. Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan-1 expressed by gingival epithelial cells.
Andrian E; Grenier D; Rouabhia M
J Cell Physiol; 2005 Jul; 204(1):178-83. PubMed ID: 15648090
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of panduratin A on c-Jun N-terminal kinase and activator protein-1 signaling involved in Porphyromonas gingivalis supernatant-stimulated matrix metalloproteinase-9 expression in human oral epidermoid cells.
Yanti ; Lee M; Kim D; Hwang JK
Biol Pharm Bull; 2009 Oct; 32(10):1770-5. PubMed ID: 19801842
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
Feldman M; Santos J; Grenier D
J Nat Prod; 2011 Sep; 74(9):1862-7. PubMed ID: 21866899
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, Evaluation of Antimicrobial Activity and Docking Studies of New Thiazole-based Chalcones.
Tratrat C; Haroun M; Xenikakis I; Liaras K; Tsolaki E; Eleftheriou P; Petrou A; Aldhubiab B; Attimarad M; Venugopala KN; Harsha S; Elsewedy HS; Geronikaki A; Soković M
Curr Top Med Chem; 2019; 19(5):356-375. PubMed ID: 30706816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
